Trademark Overview
On Tuesday, April 28, 2026, a trademark application was filed for STOCKHOLM3 BEYOND PSA with the United States Patent and Trademark Office. The USPTO has given the STOCKHOLM3 BEYOND PSA trademark a serial number of 79454528. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, July 16, 2026. This trademark is owned by A3P Biomedical AB (publ). The STOCKHOLM3 BEYOND PSA trademark is filed in the Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
IT integration services; computer software development, programming and implementation for others; website hosting services; software as a service (SaaS) featuring computer software for calculating prostate cancer risk scores; rental of computer software for use in calculating cancer risk; providing temporary use of online non-downloadable computer software for calculating prostate cancer risk scores; application service provider featuring computer software for calculating prostate cancer risk scores; scientific research and analysis in the field of prostate cancer; medical and pharmacological research services in the field of prostate cancer; conducting clinical trials for others in the field of prostate cancer; scientific and medical research in the field of oncology and urology; providing medical and scientific research information in the fields of pharmaceuticals and clinical trials; providing information on clinical studies via an interactive website.
Downloadable software for calculating the risk of prostate cancer; downloadable computer programs for calculating the risk of prostate cancer; downloadable computer software for prostate cancer testing; downloadable application software for calculating the risk of prostate cancer; scientific research and laboratory apparatus for measuring, quantification and analysis of proteins and genetic material; medical training simulators for educational purposes in the field of prostate cancer; scientific research and laboratory instruments for detecting proteins and genetic material for medical research and training purposes; computer peripherals devices.
Medical instruments, namely, protein and genetic measuring instruments for medical diagnostic purposes; medical apparatus and instruments for the diagnosis, examination, monitoring and treatment of prostate cancer; medical testing apparatus and instruments for detecting and diagnosing prostate cancer; testing probes for medical diagnostic purposes; medical diagnostic tools for calculating prostate cancer risk.
Human healthcare services, namely, disease management programs; medical services in the field of oncology and urology; medical diagnostic services in the field of oncology and urology; medical diagnostic testing services for prostate cancer; prostate cancer screening services; medical analysis services for the diagnosis and treatment of cancer and related diseases; providing online information services relating to medical and diagnostic tests, namely information regarding prostate cancer tests for diagnosis and treatment purposes; phlebotomy services; medical blood testing services; blood sampling and analysis for diagnostic or treatment purposes; providing medical information relating to prostate cancer test results; providing medical information relating to medical diagnostic test results; medical analysis services for diagnostic provided by medical laboratories; medical laboratory analysis services for the analysis of samples and blood samples taken from patients for diagnostic purp...
Diagnostic test reagents for medical purposes for prostate cancer testing; pharmaceutical preparations for treatment of cancer; reagents for use in diagnostic tests for medical purposes; diagnostic test materials for medical purposes; diagnostic preparations for medical purposes; diagnostic agents for medical use.
